What is the first line antibiotic for strep throat?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Antibiotic for Strep Throat

Penicillin V (250 mg three to four times daily) or amoxicillin (50 mg/kg once daily for children, 500 mg twice daily for adults) for 10 days remains the definitive first-line treatment for strep throat. 1, 2

Primary Treatment Algorithm

For Non-Allergic Patients

Oral penicillin remains the gold standard due to proven efficacy, safety, narrow spectrum, and low cost. 1

  • Penicillin V is the drug of choice for adults and older children: 250 mg three to four times daily OR 500 mg twice daily for 10 days 2, 3
  • Amoxicillin is equally effective and preferred in young children due to better palatability: 50 mg/kg once daily (maximum 1,000 mg) OR 25 mg/kg twice daily (maximum 500 mg) for 10 days 2, 3, 4
  • Intramuscular benzathine penicillin G should be used when oral compliance is uncertain: 1.2 million units as single injection for patients ≥27 kg, or 600,000 units for patients <27 kg 1, 2, 3

The WHO Expert Committee endorsed watchful waiting and symptom relief as the first-choice approach before antibiotics, with amoxicillin or phenoxymethylpenicillin as first-choice antibiotic treatment when bacterial pharyngitis is confirmed. 1

Critical Evidence Supporting Penicillin

Penicillin and amoxicillin reduce the risk of rheumatic fever by 73% (RR 0.27; 95% CI 0.12-0.60) and decrease suppurative complications including acute otitis media (RR 0.30) and peritonsillar abscess (RR 0.15). 1

Higher-dose amoxicillin (40 mg/kg/day) achieves superior bacteriologic cure rates (79.3%) compared to standard-dose penicillin V (54.5%), suggesting that perceived penicillin failures may be due to inadequate dosing. 5

Treatment for Penicillin-Allergic Patients

Non-Immediate (Non-Anaphylactic) Allergy

First-generation cephalosporins are the preferred alternative for patients without immediate hypersensitivity reactions. 6, 2, 3

  • Cephalexin: 20 mg/kg per dose twice daily (maximum 500 mg/dose) for 10 days 6, 3
  • Cefadroxil: 30 mg/kg once daily (maximum 1 gram) for 10 days 6, 3

Cephalosporins demonstrate lower clinical relapse rates compared to penicillin (OR 0.55; 95% CI 0.31-0.99), though symptom resolution is similar. 1

Immediate/Anaphylactic Allergy

Patients with immediate hypersensitivity must avoid all beta-lactams due to up to 10% cross-reactivity risk with cephalosporins. 6, 3

Clindamycin is the preferred alternative for immediate penicillin allergy:

  • Dosing: 7 mg/kg per dose three times daily (maximum 300 mg/dose) for 10 days 6, 2, 3
  • Resistance: Approximately 1% in the United States, making it highly reliable 6, 3
  • Efficacy: High efficacy in eradicating streptococci, even in chronic carriers 6

Macrolide alternatives (use with caution due to resistance):

  • Azithromycin: 12 mg/kg once daily (maximum 500 mg) for 5 days only 6, 2, 3
  • Clarithromycin: 7.5 mg/kg per dose twice daily (maximum 250 mg/dose) for 10 days 6, 3

The FDA label explicitly states that penicillin by intramuscular route is the usual drug of choice, and azithromycin should be used as an alternative when first-line therapy cannot be used. 7

Critical Treatment Duration Requirements

A full 10-day course is mandatory for all antibiotics except azithromycin to achieve maximal pharyngeal eradication and prevent acute rheumatic fever. 1, 6, 2, 3

  • Azithromycin is the only exception, requiring only 5 days due to its prolonged tissue half-life 6, 2, 3
  • Therapy can be safely postponed up to 9 days after symptom onset and still prevent acute rheumatic fever 1
  • Shortening courses by even a few days results in appreciable increases in treatment failure rates 6

Important Resistance Considerations

Macrolide resistance among Group A Streptococcus ranges from 5-8% in the United States, though this varies geographically and temporally. 6, 3, 4

Short-course macrolide treatment shows greater risk of late bacteriological recurrence (OR 1.31; 95% CI 1.16-1.48) compared to 10-day penicillin courses. 1

Clindamycin resistance remains very low at approximately 1% in the United States, making it an excellent choice for penicillin-allergic patients. 6, 3

Common Pitfalls to Avoid

  • Never use azithromycin or macrolides as first-line when penicillin can be used—reserve for documented penicillin allergy 6, 2
  • Do not assume all penicillin-allergic patients cannot receive cephalosporins—only those with immediate/anaphylactic reactions should avoid them 6, 2
  • Never prescribe trimethoprim-sulfamethoxazole for strep throat—50% resistance rate makes it ineffective 6, 3
  • Do not use sulfonamides or tetracyclines due to high resistance rates and frequent treatment failures 3
  • Avoid prescribing shorter courses than recommended (except azithromycin's 5-day regimen)—this leads to treatment failure and complications 6
  • Do not routinely perform post-treatment cultures in asymptomatic patients who completed therapy—only consider in special circumstances like history of rheumatic fever 6

Adjunctive Therapy

For symptom management:

  • Acetaminophen or NSAIDs (ibuprofen) for moderate to severe symptoms or high fever 6, 3
  • Aspirin must be avoided in children due to Reye syndrome risk 6, 3
  • Corticosteroids are not recommended as adjunctive therapy 6, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Best Antibiotic for Strep Throat

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

First-Line Antibiotic Therapy for Streptococcal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Streptococcal Pharyngitis: Rapid Evidence Review.

American family physician, 2024

Guideline

Treatment of Streptococcal Infections in Patients with Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.